バイオコンパティブルな無薬抗菌メソフォーミュレーションとしてのメソポラス・カテキン・ナノ粒子の合成
Runfeng Lin1, Gaoyang Li1, Qianfeng He2
1School of Chemistry and Materials, Department of Chemistry, Laboratory of Advanced Materials and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Center of Chemistry for Energy Materials (2011-iChEM), Fudan University, Shanghai 200433, P. R. China.
Journal of the American Chemical Society
|September 18, 2024
まとめ
研究者らは新型のメソポラスカテキンナノ粒子を開発し 薬剤のない抗生物質の配列を作りました これらのナノ粒子はStaphylococcus aureusに対する強力な抗菌作用を示し,マウスの傷の治癒を加速します.
科学分野:
- 材料科学
- ナノテクノロジー
- 生物医学工学
背景:
- ポリフェノール化合物は抗菌性があるが,効果を高めるにはナノ構造が必要である.
- メソポラスなポリマーナノマテリアルの製造は,複雑な分子間力により困難です.
研究 の 目的:
- メソポラスなカテキンナノ粒子を製造するための新しい方法を開発する.
- これらのナノ粒子の抗菌性および傷の治癒能力を薬剤のない抗生物質製剤として評価する.
主な方法:
- バランスのとれた多変量相互作用アプローチを用いたメソポラスカテキンナノ粒子の製造.
- ナノ粒子構造,サイズ,表面積,表面電荷の特徴
- マウスモデルでの Staphylococcus aureusに対する in vitro 抗菌試験と in vivo 創傷治癒試験
主要な成果:
- オープンメソポール (∼15 nm) と高表面積 (∼106 m2 g−1) を有する均質な球形メソポール型カテキンナノ粒子を成功して合成した.
- Staphylococcus aureusに対するインビトロの有意な抗菌作用が示され,約25μg mL−1で完全に抑制された.
- マウスモデルで傷の治癒を加速し,6~8日以内に完全に閉じる.
結論:
- メソポラスカテキンナノ粒子は,薬剤の充填を必要とせず,有望な抗生物質メソフォーミュレーションを表しています.
- 抗菌効果は,ナノ粒子のメソ構造とカテキンの代謝干渉の間の相乗効果によるものである.
- このアプローチは,先進的なポリマーナノ材料と抗生物質の製剤の開発に新しい経路を提供します.
関連する概念動画
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...